Results 131 to 140 of about 7,170 (177)

Emerging antioxidant therapies in Friedreich's ataxia. [PDF]

open access: yesFront Pharmacol
Edzeamey FJ   +3 more
europepmc   +1 more source

Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model [PDF]

open access: yes, 2016
Kemp, Kevin   +10 more
core   +1 more source

Sexual dimorphism in a mouse model of Friedreich's ataxia with severe cardiomyopathy. [PDF]

open access: yesCommun Biol
Salinas L   +6 more
europepmc   +1 more source

Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich's ataxia: insights from in vitro models. [PDF]

open access: yesRedox Rep
Edzeamey FJ   +6 more
europepmc   +1 more source

Antisense oligonucleotide therapy for patients with Friedreich's ataxia carrying the c.165+5G>C splicing mutation. [PDF]

open access: yesMol Ther Nucleic Acids
Yameogo P   +6 more
europepmc   +1 more source

Functional Characterization of Parallel Fiber-Purkinje Cell Synapses in Two Friedreich's Ataxia Mouse Models. [PDF]

open access: yesCerebellum
Joseph DJ   +6 more
europepmc   +1 more source

Noninvasive vagus nerve stimulation to target gait impairment in Parkinson's disease [PDF]

open access: yes, 2019
Baker, Mark R.   +5 more
core   +1 more source

Harshly Oxidized Activated Charcoal Enhances Protein Persulfidation with Implications for Neurodegeneration as Exemplified by Friedreich's Ataxia. [PDF]

open access: yesNanomaterials (Basel)
Vo ATT   +9 more
europepmc   +1 more source

Long non-coding RNA TUG1 is downregulated in Friedreich's ataxia. [PDF]

open access: yesBrain Commun
Koka M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy